The ETS2 promoter contains an extended region of purine/pyrimidine strand asymmetry (CT tract) upstream from the start of transcription. The presence of these sequences is required for full ETS2 expression. The ETS2 CT tract was found to bind to a number of sequence-specific factors, one of which was identified as the transcription factor Sp1. Sp1 was shown to induce expression from the ETS2 promoter and the loss of putative Sp1 sites correlated with a loss of promoter activity in vivo. The transcriptional activator Pur-alpha was found to bind single-stranded DNA with a sequence specificity corresponding to the purine-rich strand of the ETS2 CT tract. These results suggest that ETS2 expression may be linked to cell cycle events through the interaction of Sp1 bound to the ETS2 promoter with a complex containing Pur-alpha.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Intramural Research (Z01)
Project #
1Z01BC005238-15
Application #
2463606
Study Section
Special Emphasis Panel (LMO)
Project Start
Project End
Budget Start
Budget End
Support Year
15
Fiscal Year
1996
Total Cost
Indirect Cost
Name
National Cancer Institute Division of Basic Sciences
Department
Type
DUNS #
City
State
Country
United States
Zip Code